Immune Response Gene Expression in Colorectal Cancer Carries Distinct Prognostic Implications According to Tissue, Stage and Site: A Prospective Retrospective Translational Study in the Context of a Hellenic Cooperative Oncology Group Randomised Trial

• George Pentheroudakis ,

  * E-mail: gpenther@otenet.gr

  Affiliation Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece

  ⨯
• Georgia Raptou,

  Affiliations Department of Pathology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece, Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Vassiliki Kotoula,

  Affiliations Department of Pathology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece, Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Ralph M. Wirtz,

  Affiliation STRATIFYER Molecular Pathology GmbH, Cologne, Germany

  ⨯
• Eleni Vrettou,

  Affiliation Department of Pathology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Vasilios Karavasilis,

  Affiliation Department of Medical Oncology, “Papageorgiou” Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Georgia Gourgioti,

  Affiliation Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece

  ⨯
• Chryssa Gakou,

  Affiliation Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Konstantinos N. Syrigos,

  Affiliation Oncology Unit GPP, "Sotiria" General Hospital, Athens School of Medicine, Athens, Greece

  ⨯
• Evangelos Bournakis,

  Affiliation Department of Clinical Therapeutics, “Alexandra” Hospital, University of Athens School of Medicine, Athens, Greece

  ⨯
• Grigorios Rallis,

  Affiliation Department of Medical Oncology, “Papageorgiou” Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• Ioannis Varthalitis,

  Affiliation Oncology Department, General Hospital of Chania, Crete, Greece

  ⨯
• Eleni Galani,

  Affiliation Second Department of Medical Oncology, “Metropolitan” Hospital, Piraeus, Greece

  ⨯
• Georgios Lazaridis,

  Affiliation Department of Medical Oncology, “Papageorgiou” Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• George Papaxoinis,

  Affiliation Oncology Section, Second Department of Internal Medicine, “Hippokration” Hospital, Athens, Greece

  ⨯
• Dimitrios Pectasides,

  Affiliation Oncology Section, Second Department of Internal Medicine, “Hippokration” Hospital, Athens, Greece

  ⨯
• Gerasimos Aravantinos,

  Affiliation Second Department of Medical Oncology, “Agii Anargiri” Cancer Hospital, Athens, Greece

  ⨯
• Thomas Makatsoris,

  Affiliation Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece

  ⨯
• Konstantine T. Kalogeras,

  Affiliations Department of Medical Oncology, “Papageorgiou” Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece, Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece

  ⨯
•  [ ... ],
• George Fountzilas

  Affiliation Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

  ⨯
• [ view all ]
• [ view less ]